In partnership with the Leona M. and Harry B. Helmsley Charitable Trust and T1D Exchange, the Juvenile Diabetes Research Foundation has announced the launch of a health policy initiative to expand access to innovative therapies for type 1 diabetes.
Funded by JDRF and the Helmsley Trust, the initiative comprises three programs that aim to support and advance the T1D healthcare landscape — T1D Unmet Need, an effort to better characterize healthcare utilization and outcomes of the T1D population by leveraging existing resources and commissioning new data collection to develop a definitive source of T1D facts and figures; Barriers to Adoption, a research program that will generate data which paves the way for adoption of future technologies that improve glucose control and reduce the burden of disease; and T1D Outcomes, an initiative to evaluate and define measures other than hemoglobin A1c that are important in measuring improved T1D clinical outcomes. T1D Exchange's role will be to provide strategic guidance, operational support, and insights and perspectives from a broad range of the T1D population.
"The health policy initiative continues JDRF’s longstanding commitment to advocacy on behalf of the T1D community," said JDRF chief mission officer Aaron J. Kowalski. "Partnering with the Helmsley Charitable Trust and T1D Exchange provides an unprecedented opportunity to leverage the reach, expertise, and impact of each organization to improve outcomes in type 1 diabetes."